Virios Therapeutics CEO Greg Duncan's 2022 pay slips 15% to $937K
Virios Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 27, 2023
Virios Therapeutics reported fiscal year 2022 executive compensation information on April 27, 2023.
In 2022, three executives at Virios Therapeutics received on average a compensation package of $643K, a 2% decrease compared to previous year.
Average pay of disclosed executives at Virios Therapeutics
Greg Duncan, Chief Executive Officer, received $937K in total, which decreased by 15% compared to 2021. 56% of Duncan's compensation, or $529K, was in salary. Duncan also received $377K in option awards and $31K in other compensation.
R. Michael Gendreau, Chief Medical Officer, received a compensation package of $566K, which decreased by 18% compared to previous year. 59% of the compensation package, or $336K, was in salary.
Angela Walsh, Senior Vice President of Finance, earned $427K in 2022, a 3% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2023.